Clinical responses to ERK inhibitor (GDC-0994) treatment combinations predicted using a Quantitative Systems Pharmacology model of MAPK signaling in BRAF(V600E)-mutant colorectal cancerDaniel C. Kirouac, Saroja Ramanujan, John S.D. Chan et al.|European Journal of Cancer|2016Cited by 2